FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, July 15, 2010

FDA Alert: Angiotensin Receptor Blockers (ARBs): Ongoing Safety Review for Cancer Risk



BACKGROUND: ARBs are used in patients with high blood pressure and other conditions. Brand names include Atacand, Avapro, Benicar, Cozaar, Diovan, Micardis, and Teveten

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.